Research

Adherence

Tirzepatide is associated with injection-site reactions, particularly pain, which are consistent with the class of GLP-1/GIP agonists and are typically mild and transient.

Injection site pain is a common side effect of tirzepatide. It is usually mild and goes away. Proper injection technique and counseling can help reduce this discomfort and help you stick with your treatment.

ModerateSupportsMEDIUM confidence
Injection-site reactions included 19,334 reports... Injection-site pain particularly prevalent... These events are typically mild and transient in nature.
Hadi A. Almansour et al. · Healthcare · 2025

Why this rating

Based on FAERS data, which reflects reporting bias but shows consistent trends.

Source

Real-World Safety Concerns of Tirzepatide: A Retrospective Analysis of FAERS Data (2022–2025)

Hadi A. Almansour et al. · Healthcare · 2025

DOI 10.3390/healthcare13182259

cohort · n=65974Cited 2×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →